Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2410542
Affiliations:
22
Authors:
24
Institutions Authors Share
Savara, United States of America (USA)
5.000000
0.21
IRCCS Policlinico San Matteo, Italy
2.000000
0.08
Kinki-chuo Chest Medical Center, Japan
1.500000
0.06
University of Cincinnati (UC), United States of America (USA)
1.166667
0.05
Marius Nasta Institute of Pneumology, Romania
1.000000
0.04
Ege University Hospital, Turkey
1.000000
0.04
Saitama Red Cross Hospital, Japan
1.000000
0.04
University of Florida (UF), United States of America (USA)
1.000000
0.04
St. Vincent's University Hospital, Ireland
1.000000
0.04
Asan Medical Center (AMC), South Korea
1.000000
0.04
University of Health Sciences (SBU), Turkey
1.000000
0.04
University of California, Los Angeles (UCLA), United States of America (USA)
1.000000
0.04
Tohoku University, Japan
1.000000
0.04
University of Duisburg-Essen (UDE), Germany
1.000000
0.04
Kanagawa Cardiovascular and Respiratory Center, Japan
1.000000
0.04
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)
0.833333
0.03
Aarhus University (AU), Denmark
0.500000
0.02
Aarhus University Hospital, Denmark
0.500000
0.02
Hôpital Pontchaillou, France
0.500000
0.02
Institut de Recherche en Santé, Environnement et Travail (IRSET), France
0.500000
0.02
Osaka Fukujuji Hospital, Osaka Anti-Tuberculosis Association, Japan
0.500000
0.02